Korro Bio (KRRO) Shares Outstanding (2018 - 2026)
Korro Bio (KRRO) posted Shares Outstanding (Entity) of $1.5 million for Q4 2023, up 107.08% on a QoQ basis from $738526.0 in Q3 2023, and up 499.32% year-over-year from $255175.0 in Q4 2022.
Korro Bio (KRRO) Shares Outstanding (2018 - 2026) Analysis & Trends
Korro Bio's Shares Outstanding (Entity) history runs 5 years deep, the most recent figure standing at $1.5 million for Q4 2023.
- Quarterly Shares Outstanding (Entity) rose 499.32% year-over-year to $1.5 million in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $1.5 million (up 499.32% YoY) and the FY2023 annual result came in at $1.5 million, up 499.32% from the prior year.
- Shares Outstanding (Entity) was $1.5 million for Q4 2023 at Korro Bio, up from $738526.0 in the prior quarter.
- Across five years, Shares Outstanding (Entity) topped out at $1.5 million in Q4 2023 and bottomed at $172985.0 in Q4 2019.
- A 5-year average of $629571.6 and a median of $684324.0 in 2021 frame the typical range for Shares Outstanding (Entity).
- Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) slumped 63.14% — and 2023, when it surged 499.32%.
- Korro Bio's Shares Outstanding (Entity) stood at $172985.0 in 2019, then jumped by 292.68% to $679280.0 in 2020, then rose by 1.91% to $692224.0 in 2021, then slumped by 63.14% to $255175.0 in 2022, then jumped by 499.32% to $1.5 million in 2023.
- Business Quant data shows KRRO's Shares Outstanding (Entity) at $1.5 million in Q4 2023, $738526.0 in Q3 2023, and $276482.0 in Q2 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,981.90 Bn | 66,981.62 Bn | - | 6,012.74 Bn |
| 2 | Nanobiotix | 1,913.50 Bn | 1,913.44 Bn | - | 47.82 Bn |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | 118.76 Bn |
| 4 | BeOne Medicines | 472.03 Bn | 467.24 Bn | 1.35 Bn | 1.44 Bn |
| 5 | Vertex Pharmaceuticals | 122.09 Bn | 114.84 Bn | 2.59 Bn | 254.10 Mn |
| 6 | Regeneron Pharmaceuticals | 70.01 Bn | 61.26 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - | 400.00 Mn |
| 8 | Argenx Se | 55.99 Bn | 50.80 Bn | 1.41 Bn | 62.19 Mn |
| 9 | Alnylam Pharmaceuticals | 37.49 Bn | 34.48 Bn | 959.66 Mn | 132.89 Mn |
| 10 | Korro Bio | 122.37 Mn | 8.40 Mn | - | 11.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.60 Mn |
| Dec 31, 2025 | 9.40 Mn |
| Sep 30, 2025 | 9.39 Mn |
| Jun 30, 2025 | 9.39 Mn |
| Mar 31, 2025 | 9.38 Mn |
| Dec 31, 2024 | 8.92 Mn |
| Sep 30, 2024 | 9.30 Mn |
| Jun 30, 2024 | 8.99 Mn |
| Mar 31, 2024 | 8.02 Mn |
| Dec 31, 2023 | 1.53 Mn |
| Sep 30, 2023 | 738,445.00 |
| Jun 30, 2023 | 276,482.00 |
| Mar 31, 2023 | 271,522.00 |
| Dec 31, 2022 | 255,175.00 |
| Sep 30, 2022 | 704,954.00 |
| Jun 30, 2022 | 699,528.00 |
| Mar 31, 2022 | 696,214.00 |
| Dec 31, 2021 | 687,025.00 |
| Sep 30, 2021 | 688,975.00 |
| Jun 30, 2021 | 684,768.00 |